D. Foster

发表

Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatography.

A. Somogyi, F. Bochner, D. Foster, 2000, Journal of chromatography. B, Biomedical sciences and applications.

THE EFFECTS OF ISOSTEVIOL AGAINST MYOCARDIUM INJURY INDUCED BY ISCHAEMIA–REPERFUSION IN THE ISOLATED GUINEA PIG HEART

D. J. Foster, Deyi Xu, Shuangjie Zhang, 2007, Clinical and experimental pharmacology & physiology.

Steady‐state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration‐effect relationships

A. Somogyi, F. Bochner, J. White, 1999, Clinical pharmacology and therapeutics.

Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.

A. Somogyi, R. Ali, F. Bochner, 2004, British journal of clinical pharmacology.

Stereoselective Quantification of Methadone and a d6-labeled Isotopomer Using High Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization Mass-Spectrometry: Application to a Pharmacokinetic Study in a Methadone Maintained Subject

A. Somogyi, T. Mürdter, G. Heinkele, 2006, Therapeutic drug monitoring.

Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration

M. Wiese, R. Upton, S. Proudman, 2017, Drug Metabolism and Disposition.

Limited fetal metabolism of rosiglitazone: Elimination via the maternal compartment in the pregnant ewe.

J. Morrison, A. Davey, B. Muhlhausler, 2016, Reproductive toxicology.

Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method

A. Davey, B. Muhlhausler, M. Bazargan, 2017, Drugs in R&D.

Blood–brain equilibration kinetics of levo‐α‐acetyl‐methadol using a chronically instrumented sheep preparation

R. Upton, A. Somogyi, C. Grant, 2006, British journal of pharmacology.

The Acute Disposition of (R)- and (S)-Methadone in Brain and Lung of Sheep

R. Upton, A. Somogyi, C. Grant, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.

A. Somogyi, F. Bochner, D. Foster, 1999, British journal of clinical pharmacology.

Simple HPLC method for determination of rosiglitazone in sheep plasma and amniotic fluid and its application in a pregnant sheep model.

J. Morrison, A. Davey, B. Muhlhausler, 2011, Journal of pharmaceutical and biomedical analysis.

Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

A. Somogyi, F. Bochner, J. White, 2000, British journal of clinical pharmacology.

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

A. Somogyi, M. Hutchinson, J. Coller, 2003, British Journal of Clinical Pharmacology.

The Relationship Between Mood State and Plasma Methadone Concentration in Maintenance Patients

A. Somogyi, F. Bochner, K. Dyer, 2001, Journal of clinical psychopharmacology.

Individualization of leflunomide dosing in rheumatoid arthritis patients.

M. Wiese, R. Upton, S. Proudman, 2014, Personalized medicine.

ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics

A. Somogyi, D. Barratt, A. Byrne, 2012, Pharmacogenomics and personalized medicine.

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

A. Somogyi, F. Bochner, D. Foster, 2004, British journal of clinical pharmacology.

Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.

B. Sallustio, D. Foster, 1995, Drug Metabolism And Disposition.

A phase I study of the GM-CSF antagonist E21R

M. Brown, Angel F. Lopez, A. Somogyi, 2002, Cancer Chemotherapy and Pharmacology.

Inside the isomers: the tale of chiral switches

A. Somogyi, F. Bochner, D. Foster, 2004 .

Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.

A. Somogyi, D. J. Foster, Glynn A. Morrish, 2006, British journal of clinical pharmacology.

Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs

M. Wiese, S. Proudman, M. Sorich, 2020, Scientific Reports.

Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone.

A. Somogyi, L. Christrup, D. Gillis, 2007, International journal of clinical pharmacology and therapeutics.

Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.

A. Somogyi, F. Bochner, A. Salter, 2005, British journal of clinical pharmacology.

A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity.

M. Wiese, R. Upton, S. Proudman, 2016, British journal of clinical pharmacology.